Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Jeddeloh, Stephen Macevicz, Christine Peponnet

Jeffrey Jeddeloh, Stephen Macevicz, and Christine Peponnet have joined the new US subsidiary of French DNA synthesis firm DNA Script.  

Jeddeloh was appointed as vice president of business development and commercial strategy. Most recently, he was director of business development for Roche Molecular Solutions. Prior to that, he was R&D director at Orion Genomics. He holds a PhD from Washington University and an MBA from the University of Wisconsin.

Macevicz has become the firm's vice president of intellectual property. Previously, he was vice president of IP at Sequenta and at Ion Torrent, as well as senior IP attorney at Becton Dickinson. He holds a PhD in biophysics and a JD from the University of California, Berkeley.

Peponnet has joined the company as vice president of technology development. Most recently, she was head of the biosystems group at CEA (Center for Atomic Energy), where she helped to develop a microfluidic technology that was licensed to Advanced Liquid Logic, which was later acquired by Illumina. Prior to that, she worked at Caliper Technologies, and before that, she was head of genotyping R&D at Genset.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.